| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
131,150 |
99,960 |
$18.72M |
| 00003 |
Internal/system code - not a standard HCPCS code |
2,640 |
2,442 |
$654K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
125,570 |
68,913 |
$290K |
| 90834 |
Psychotherapy, 45 minutes with patient |
8,851 |
4,176 |
$215K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55,317 |
31,345 |
$94K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,262 |
6,016 |
$80K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
7,665 |
6,624 |
$46K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,119 |
2,851 |
$43K |
| 0001A |
|
1,216 |
697 |
$40K |
| 0002A |
|
1,172 |
674 |
$37K |
| 0012A |
|
510 |
310 |
$19K |
| 90756 |
|
958 |
887 |
$16K |
| 0011A |
|
525 |
300 |
$14K |
| 0004A |
|
455 |
296 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,253 |
1,872 |
$11K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,435 |
2,214 |
$10K |
| 90674 |
|
968 |
867 |
$10K |
| 90686 |
|
3,531 |
3,105 |
$9K |
| 0071A |
|
522 |
325 |
$8K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,835 |
1,859 |
$8K |
| 96127 |
|
62,666 |
44,659 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,415 |
2,119 |
$7K |
| 90715 |
|
985 |
891 |
$6K |
| 0072A |
|
364 |
224 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,310 |
2,716 |
$6K |
| G9920 |
Screening performed and negative |
4,174 |
3,810 |
$6K |
| 0064A |
|
235 |
126 |
$5K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
10,129 |
6,419 |
$5K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
240 |
169 |
$4K |
| 0124A |
|
243 |
209 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
919 |
605 |
$4K |
| H0049 |
Alcohol and/or drug screening |
374 |
358 |
$4K |
| 92551 |
|
6,640 |
5,990 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,452 |
1,749 |
$3K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
767 |
529 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,437 |
1,054 |
$3K |
| 81025 |
|
3,758 |
3,310 |
$3K |
| 90651 |
|
974 |
857 |
$3K |
| 99173 |
|
6,644 |
5,993 |
$2K |
| 90670 |
|
985 |
858 |
$2K |
| 0031A |
|
91 |
50 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
470 |
337 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
263 |
170 |
$2K |
| 90734 |
|
524 |
457 |
$2K |
| 96156 |
|
773 |
672 |
$1K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
245 |
221 |
$1K |
| 3008F |
|
76,269 |
61,308 |
$1K |
| J3490 |
Unclassified drugs |
38 |
31 |
$1K |
| 3078F |
|
29,313 |
23,385 |
$1K |
| 90656 |
|
286 |
284 |
$1K |
| 99385 |
|
160 |
97 |
$1K |
| 82962 |
|
7,350 |
5,800 |
$1K |
| 3074F |
|
32,113 |
25,396 |
$927.34 |
| 99201 |
|
910 |
859 |
$868.33 |
| 90633 |
|
442 |
375 |
$841.48 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
68 |
45 |
$623.77 |
| 80061 |
Lipid panel |
3,851 |
3,598 |
$620.19 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25 |
25 |
$603.90 |
| 86318 |
|
2,145 |
1,643 |
$595.76 |
| 90677 |
|
151 |
150 |
$558.00 |
| 90647 |
|
429 |
358 |
$513.18 |
| 90620 |
|
100 |
84 |
$491.76 |
| 97803 |
|
668 |
577 |
$460.49 |
| 90791 |
Psychiatric diagnostic evaluation |
54 |
37 |
$457.03 |
| T1016 |
Case management, each 15 minutes |
326 |
274 |
$377.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
424 |
328 |
$349.19 |
| 69210 |
|
358 |
346 |
$319.41 |
| 81002 |
|
2,771 |
2,430 |
$298.62 |
| 90723 |
|
401 |
349 |
$296.91 |
| 99401 |
|
408 |
350 |
$216.98 |
| 99000 |
|
1,493 |
1,126 |
$212.02 |
| 90710 |
|
146 |
97 |
$198.00 |
| 92552 |
|
154 |
152 |
$134.67 |
| 90661 |
|
540 |
539 |
$114.37 |
| 92250 |
|
36 |
36 |
$112.84 |
| 90688 |
|
102 |
99 |
$112.30 |
| 3725F |
|
12,812 |
8,070 |
$98.68 |
| 99383 |
|
44 |
27 |
$93.58 |
| 90681 |
|
65 |
65 |
$81.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
64 |
64 |
$67.01 |
| 90697 |
|
60 |
60 |
$63.00 |
| 99384 |
|
18 |
12 |
$54.59 |
| 90707 |
|
58 |
52 |
$54.00 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
399 |
313 |
$53.75 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
83 |
69 |
$47.86 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
57 |
57 |
$44.80 |
| 3077F |
|
3,367 |
2,845 |
$43.65 |
| 90696 |
|
46 |
29 |
$36.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
695 |
682 |
$33.27 |
| 0502F |
|
4,591 |
2,457 |
$28.83 |
| 1111F |
|
1,615 |
1,426 |
$28.68 |
| 1160F |
|
2,004 |
1,799 |
$28.63 |
| 82274 |
|
173 |
167 |
$28.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
217 |
194 |
$27.68 |
| 91300 |
|
1,525 |
1,139 |
$27.00 |
| 3079F |
|
10,280 |
8,763 |
$24.08 |
| 3075F |
|
5,865 |
5,163 |
$24.05 |
| 85018 |
|
359 |
342 |
$16.17 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
177 |
127 |
$8.08 |
| 91307 |
|
707 |
508 |
$4.81 |
| 1159F |
|
1,992 |
1,787 |
$0.11 |
| 2022F |
|
72 |
63 |
$0.05 |
| 3080F |
|
1,041 |
906 |
$0.04 |
| 1158F |
|
947 |
833 |
$0.01 |
| 2028F |
|
566 |
516 |
$0.01 |
| 90716 |
|
58 |
52 |
$0.01 |
| Z6304 |
|
1,048 |
797 |
$0.00 |
| NOBLL |
|
86 |
69 |
$0.00 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
37 |
27 |
$0.00 |
| 86703 |
|
51 |
40 |
$0.00 |
| 99397 |
|
67 |
62 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
54 |
52 |
$0.00 |
| Z6500 |
|
42 |
42 |
$0.00 |
| 99177 |
|
12 |
12 |
$0.00 |
| 1090F |
|
67 |
65 |
$0.00 |
| 99497 |
|
54 |
52 |
$0.00 |
| 3288F |
|
55 |
53 |
$0.00 |
| 1003F |
|
55 |
53 |
$0.00 |
| 4004F |
|
14 |
13 |
$0.00 |
| 86328 |
|
52 |
40 |
$0.00 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
32 |
17 |
$0.00 |
| G0468 |
Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv |
27 |
26 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
32 |
26 |
$0.00 |
| 90685 |
|
39 |
38 |
$0.00 |
| 0121A |
|
13 |
13 |
$0.00 |
| 01 |
Inj., retisert, 0.01 mg |
80 |
75 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
77 |
66 |
$0.00 |
| 92060 |
|
159 |
159 |
$0.00 |
| Z6204 |
|
1,033 |
784 |
$0.00 |
| Z6404 |
|
1,030 |
781 |
$0.00 |
| 91306 |
|
158 |
107 |
$0.00 |
| 90839 |
|
207 |
134 |
$0.00 |
| 91301 |
|
464 |
369 |
$0.00 |
| 86580 |
|
26 |
26 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
14 |
12 |
$0.00 |
| 3044F |
|
21 |
12 |
$0.00 |
| 1170F |
|
55 |
53 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
13 |
$0.00 |
| 91303 |
|
57 |
42 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
89 |
71 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
62 |
50 |
$0.00 |
| 93000 |
|
30 |
25 |
$0.00 |
| 87340 |
|
34 |
28 |
$0.00 |
| 99386 |
|
45 |
40 |
$0.00 |
| 1126F |
|
26 |
25 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
38 |
29 |
$0.00 |
| 4086F |
|
12 |
12 |
$0.00 |
| 1034F |
|
14 |
13 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
32 |
26 |
$0.00 |
| Z1032 |
|
24 |
12 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
25 |
17 |
$0.00 |
| 3061F |
|
21 |
14 |
$0.00 |